Navigation Links
Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
Date:6/18/2008

FORT LAUDERDALE, Fla., June 18 /PRNewswire-FirstCall/ -- Synovics Pharmaceuticals, Inc. (OTC Bulletin Board: SYVC), a specialty pharmaceutical company, today announced that its wholly owned subsidiary, Kirk Pharmaceuticals, LLC (Kirk) during the past year has added Dollar General and K-Mart to their growing list of clients that includes Target, Walgreens, Family Dollar, HEB and many others. The products contracted for by these retailers are all over-the-counter (OTC) private label or "store brand" drugs.

"Kirk's new customers are the result of a successful ongoing total effort by our overall Kirk operation working with our sales team to grow our OTC private label business," stated Stephen Friedman, Kirk's acting Sr. VP of Marketing and Sales. "Our mission is to offer our customers a complete range of high-quality, competitively priced products in the large analgesic, cough, cold and laxative segments where store brands exceed 30% of their total respective category sales."

Friedman goes on to say that, "Kirk, as an organization, is highly committed to providing our customers their three most valued expectations: quality, price and customer service. We have made a Company-wide effort to build our customer service level to meet the high standard of service our customers require and deserve. The success of this effort is now being reflected in a growth of our private label sales and Company revenues. We appreciate these companies as valued customers and are very grateful for the confidence they have shown us. We believe that with a continuation of this effort we have the promise of even better results."

"We are most pleased with these important new customer relationships," commented Ronald Howard Lane, Ph.D., Synovics' Chairman and Chief Executive Officer. "It is most rewarding to see the outcome of the commitment and hard work of the Company's people being reflected in its customer service and potentially multi-million dollar orders from the
'/>"/>

SOURCE Synovics Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... May 01, 2015 Spirax Sarco, the ... extremely proud to announce that for the first time ... a winner of a Queen’s Award for Innovation – ... design and manufacture of a unique flowmeter. , The ... alternative to traditional steam flow measurement. The device ...
(Date:4/30/2015)... SAN DIEGO , April 30, 2015   ... drugs, announced today an update on its Ebola antiviral ... of Tamir,s leading candidates, TMR004, is currently being evaluated ... frontline of the battle against Ebola. During the first ... Voice And Leadership Meeting To Accelerate The Evaluation of ...
(Date:4/30/2015)... , April 30, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... chemicals, today announced that it has commenced an underwritten public ... to grant the underwriters a 30-day option to purchase ... of common stock offered in the public offering. The ... be no assurance as to whether or when the ...
(Date:4/30/2015)... , April 30, 2015 Oxford Finance ... debt to life sciences and healthcare services companies, today ... term loan agreement with Celula, Inc., a diagnostic testing ... diseases, enabling better patient care and improved outcomes.  Proceeds ... development and expand the commercialization of its products in ...
Breaking Biology Technology:Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 2Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 4BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3Oxford Finance Provides $10 Million Debt Financing to Celula 2
... Cardiac Science Corporation, an Opto Circuits Group ... defibrillator (AED) and diagnostic cardiac monitoring devices, announced ... G3 Pro® units to the Hong Kong Department ... http://photos.prnewswire.com/prnh/20080306/AQTH510LOGO ) "This alliance demonstrates ...
... LA JOLLA, Calif., Nov. 15, 2011 DermTech, ... disease detection, announced  it will present results from ... can be used with a high-throughput, low-cost qRT-PCR ... recapitulated on a qRT-PCR system that successfully discriminated ...
... Virobay, Inc., a privately held ... protease inhibitors for the treatment of autoimmune diseases, ... showing that one of the company,s spectrum-selective cathepsin ... bone cancer pain.  Virobay has a series of ...
Cached Biology Technology:Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs 2Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs 3Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs 4DermTech's Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study 2DermTech's Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study 3Virobay's Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model 2Virobay's Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model 3
(Date:3/24/2015)... Mar. 24, 2015 Research and Markets ... "Global Iris Recognition Market 2015-2019" report to ... Iris Recognition market to grow at a CAGR of ... report covers the present scenario and the growth prospects ... 2015-2019. To calculate the market size, the report considers ...
(Date:3/23/2015)... March 23, 2015   HOYOS Labs , a ... today announced that the Company will demonstrate multiple biometrics-based ... and consumers at Connect:ID on March 23 through 25, ... Labs will highlight the IEEE Biometric Open Protocol Standard; ... and enterprise access control system. BOPS was invented by ...
(Date:3/20/2015)... March 20, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... one of the products featured in 2015 "I Want ... 11:00 PM EST on the DIY Network.   ... Las Vegas , site of the 2015 International ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... are the first to observe the dynamic, ratchet-like movements ... proteins from genetic blueprints. Their study, published ... in the interplay of molecules that allows cells to ... use a variety of tools to build proteins, beginning ...
... of applying the strange properties of quantum mechanics to ... by a series of recent developments. The exciting progress ... and discussed recently at a high level conference organised ... Fonds zur Frderung der wissenschaftlichen Forschung in sterreich (FWF) ...
... NY, June 5, 2008 Allan C. Spradling, Ph.D., ... Medical Institute (HHMI) in Baltimore, is the recipient of ... Gruber Foundation for his work on fruit fly genomics ... reproduction." , For his contribution to developmental genetics, Spradling, ...
Cached Biology News:Researchers observe spontaneous 'ratcheting' of single ribosome molecules 2Researchers observe spontaneous 'ratcheting' of single ribosome molecules 3Europe gets together to harness quantum physics 2Europe gets together to harness quantum physics 3Europe gets together to harness quantum physics 4Spradling receives Gruber Foundation Genetics Prize for new genetic techniques 2Spradling receives Gruber Foundation Genetics Prize for new genetic techniques 3Spradling receives Gruber Foundation Genetics Prize for new genetic techniques 4
mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...
Anti-Salmonid Ig (H), Alk Phos, (Clone IPA5F12) (mouse IgG2a)...
Rat monoclonal [HK5.3] to B7 RP1 (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
... with the HECT protein, E6-AP ... Evidence suggests that this E2 ... degradation of non-""N-end rule"" protein ... -acetylated proteins as well as ...
Biology Products: